| Dec'19 | Sep'19 | Jun'19 | Dec'18 | Sep'18 | Jun'18 | |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income (loss) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||||||
Loss from Equity Method Investment in the Joint Venture | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Deferred income tax expense (benefit) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
(Gain) Loss on Sale of Interests in the Joint Venture | ||||||
- | - | - | 0 | 0 | 0 | |
Changes in operating assets and liabilities: | ||||||
Due from the Joint Venture | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Income taxes receivable | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Accrued expenses | ||||||
- | - | 0 | - | - | 0 | |
Due to the Joint Venture | ||||||
- | - | - | 0 | 0 | 0 | |
Cash flows from investing activities: | ||||||
Proceeds from sale of interests in Joint Venture | ||||||
- | - | - | 0 | 0 | 0 | |
Net cash provided by (used in) investing activities | ||||||
- | - | - | 0 | 0 | 0 | |
Cash flows from financing activities: | ||||||
Payments to acquire common stock | ||||||
- | - | - | 0 | 0 | 0 | |
Net cash provided by (used in) financing activities | ||||||
- | - | - | 0 | 0 | 0 | |